VX-128

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVX-128
Drug Alias NameVX-128
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertex Pharmaceuticals Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesVertex Pharmaceuticals Incorporated
Inactive CompaniesN/A
Active IndicationsAcute Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A